Stock screenerAll disclosures →
EDGAR →
FATE
Conviction 99HealthcareScan · Mon, Aug 10, 2026FATE$2.75-1.79%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 2.59M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.75
Change-1.79%
Gap+0.00%
Rel volume3.41×
Avg volume2.48M
Avg $ vol6.58M
SMA 202.62
SMA 502.48
SMA 2001.60
Price vs 50+10.70%
Price vs 200+71.54%
MA stackbullish
50/200 cross—
Supertrendup · 2.22
RSI (14)56
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D79 / 68
ADX (14)17
+DI / −DI22 / 18
RSI divergence—
MACD divergence—
ATR %+7.72%
ADR %7.13%
52w high3.11
52w low0.9214
From 52w high-11.58%
Above 52w low+198.46%
New 52w highNo
SqueezeOff
Bollinger width29.76%
%B0.67
Donchian pos59.17%
Donchian high3.10
Donchian low2.25
AVWAP (52w high)2.70
vs AVWAP high+1.77%
AVWAP (52w low)1.75
vs AVWAP low+56.80%
OBV trendFlat
Chaikin MF (20)-0.21
Today vs 20d3.41×
Avg vol (14d)2.59M
Avg vol (20d)2.48M
Avg $ vol (20d)6.58M
Market cap320.54M
RS 3m (vs SPY)+9.53%
RS 6m (vs SPY)+152.55%
RS line new highNo
Trend template8/8
Technical rank80.2
1 week+10.00%
1 month-11.29%
3 months+15.06%
6 months+141.23%
1 year+180.58%
YTD+178.79%
P/E-2.35
P/B1.78
P/S48.23
P/FCF-2.86
EPS-1.15
Div yield—
ROE-75.85%
ROA-47.84%
Debt/Eq0.13
Current5.85
EV/EBITDA-2.26
Gross margin—
Net margin—
Rev growth-51.24%
EPS growth26.82%
Price target5.24
Target upside90.55%
Analyst ratingBuy
Institutional67.73%
Ent. value304.37M
Revenue1.3M
Net income-31.21M
Gross profit—
Free cash flow-112.04M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out—
Employees161
ListedTue, Oct 1, 2013
Free float98.83M
Float %85.0%
Short interest7.32M
Days to cover2.0d
Short volume54.6%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.26 vs −$0.29
Last surprise+10.3% beat
Setup gradeA+
Conviction99 / 100
Pattern quality—
Tech rank80.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.22
Support1.84
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in FATE
No recent disclosed trades by Congress in FATE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in FATE · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Valamehr Bahram President and CEO · Common Stock · 2026-08-04 | Sell | 43.95K | $108K | 2026-08-04 | 2026-08-05 |
TAHL CINDY See Remarks · Common Stock · 2026-08-04 | Sell | 38.8K | $95K | 2026-08-04 | 2026-08-05 |
Valamehr Bahram President and CEO · Common Stock · 2026-05-20 | Sell | 28.95K | $54K | 2026-05-20 | 2026-05-21 |
TAHL CINDY See Remarks · Common Stock · 2026-05-20 | Sell | 25.59K | $48K | 2026-05-20 | 2026-05-21 |
TAHL CINDY See Remarks · Common Stock · 2026-05-06 | Exercise | 122.22K | $161K | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Stock Option (Right to Buy) · 2026-05-06 | Exercise | 44.44K | $0 | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Stock Option (Right to Buy) · 2026-05-06 | Exercise | 122.22K | $0 | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Common Stock · 2026-05-06 | Exercise | 44.44K | $47K | 2026-05-06 | 2026-05-07 |
EPSTEIN ROBERT S Director · Stock Option (Right to Buy) · 2026-05-05 | Exercise | 25K | $0 | 2026-05-05 | 2026-05-06 |
RASTETTER WILLIAM H Director · Common Stock · 2026-05-05 | Other | — | — | 2026-05-05 | 2026-05-06 |
SEC filings
EDGAR filings in FATE · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.